A Multicenter, Single-Arm, Phase II Trial of RC48-ADC Combined with Radiotherapy, PD-1/PD-L1 Inhibitor Sequential GM-CSF and IL-2 (prag3.0 Regimen) for the Treatment of HER2-Expressing Advanced Solid Tumors
JOURNAL OF CLINICAL ONCOLOGY（2023）
Key words
Cancer Immunoediting,Cancer Cell Metabolism
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined